Vimarsana
Biggest News Aggregation in the World

Page 30 - Double Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Study Today - Breaking & Trending Today

US Senate Confirms Monica Bertagnolli as NIH Director - Vimarsana News

US Senate Confirms Monica Bertagnolli as NIH Director

The US Senate on Tuesday voted to confirm President Joe Biden's pick to run the National Institutes of Health, Monica Bertagnolli.

Pfizer to Price COVID Treatment Paxlovid at $1390 Per Course - Vimarsana News

Pfizer to Price COVID Treatment Paxlovid at $1390 Per Course

Pfizer on Wednesday said it will set the US price for its COVID-19 antiviral treatment Paxlovid at nearly $1400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it.

Real-World Semaglutide Weight Loss Below Trial Levels - Vimarsana News

Real-World Semaglutide Weight Loss Below Trial Levels

In practice, patients may not lose as much weight with semaglutide as the clinical trials suggest, depending on individual factors.

NIH Begins Human Trials of 'Universal' Flu Vaccine - Vimarsana News

NIH Begins Human Trials of 'Universal' Flu Vaccine

The National Institutes of Health has begun an early stage study on its experimental vaccine targeting six strains of influenza virus.

ICON to Partner With US Govt Agency to Test COVID Vaccine Candidates - Vimarsana News

ICON to Partner With US Govt Agency to Test COVID Vaccine Candidates

Contract research firm ICON said on Wednesday it is partnering with the US government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.